Collegium Pharmaceutical Inc. and United Research Laboratories/Mutual Pharmaceutical Company Announce Product Development Agreement.CUMBERLAND, R.I. -- Collegium col·le·gi·um n. pl. col·le·gi·a or col·le·gi·ums 1. An executive council or committee of equally empowered members, especially one supervising an industry, commissariat, or other organization in the Soviet Union. Pharmaceutical, Inc., a specialty pharmaceutical product development company, and URL/Mutual Pharmaceutical Company, a privately-held company that is engaged in the research, development, manufacturing and commercialization of generic pharmaceutical products, today announced that they entered into a Product Development Agreement for the development and commercialization of an undisclosed product. Collegium is responsible for all aspects of formulation formulation /for·mu·la·tion/ (for?mu-la´shun) the act or product of formulating. American Law Institute Formulation development, process development, analytical analytical, analytic pertaining to or emanating from analysis. analytical control control of confounding by analysis of the results of a trial or test. development, manufacturing of clinical batches and pilot bioavailability bioavailability /bio·avail·a·bil·i·ty/ (bi?o-ah-val?ah-bil´i-te) the degree to which a drug or other substance becomes available to the target tissue after administration. bi·o·a·vail·a·bil·i·ty n. for the product. After such point, Collegium will transfer the technology to URL/Mutual for pivotal bioavailability, commercial manufacturing and commercialization of the product. URL/Mutual will also be responsible for all required regulatory filings. The companies expect that the product will be available for launch in late 2006 or early 2007. The agreement calls for Collegium to be paid certain milestones associated with the development of the product in addition to royalties on the net sales Net Sales The amount a seller receives from the buyer after costs associated with the sale are deducted. Notes: This amount is calculated by subtracting the following items from gross sales: merchandise returned for credit, allowances for damaged or missing goods, freight of the product. "We are very pleased to have entered into this agreement with URL/Mutual. We feel this product leverages Collegium's formulation development expertise and that URL/Mutual is an exceptional partner to commercialize this product due to their broad product line, distribution capabilities and reputation" said Michael Heffernan Michael Heffernan (3 April, 1885 – 21 November, 1970) was an Irish Farmers' Party politician. He was first elected to Dáil Éireann in 1927 as a TD for Tipperary. He served as Parliamentary Secretary to the Minister for Posts and Telegraphs from 1927 to 1932. , President of Collegium. Collegium's business model is to develop differentiated, patent protected or high barrier to entry products, complete "proof of concept" studies and then out-license the products for commercialization by a strategic marketing partner. Dr. Richard Roberts Richard Roberts may refer to:
About United Research Laboratories/Mutual Pharmaceutical Company United Research Laboratories/Mutual Pharmaceutical Company, a privately-held company headquartered in Philadelphia, is engaged in the research, development, manufacturing and commercialization of generic and branded pharmaceutical products, and the application of innovative intellectual property strategies to existing and future branded products. URL/Mutual currently has 250 ANDA ANDA abbr. abbreviated new drug application approvals, 4 NDA (Non Disclosure Agreement) An agreement signed between two parties that have to disclose confidential information to each other in order to do business. In general, the NDA states why the information is being divulged and stipulates that it cannot be used for any approvals, a rapidly growing pipeline of generic and branded products, and currently manufactures 2.3 billion units annually. For more information, please visit www.urlmutual.com. Contact United Research Laboratories/Mutual Pharmaceutical Company William J. Sirico United Research Laboratories Mutual Pharmaceutical Company 215-807-1045 wsirico@urlmutual.com About Collegium Pharmaceutical, Inc. Collegium Pharmaceutical, Inc., is a privately held pharmaceutical company focused on the development of proprietary, late stage pharmaceutical products. These products target market opportunities through product enhancements and line extension strategies protected by intellectual property (IP). Collegium applies customized pharmaceutical formulations Pharmaceutical formulation, in pharmaceutics, is the process in which different chemical substances are combined to a pure drug substance to produce a final medicinal product. and IP strategies to drugs that are safe and effective, creating a portfolio of improved pharmaceutical products with potentially less development risk and shorter times to market. Collegium uses its broad expertise in IP development, drug formulation, manufacturing, basic science (chemistry, biology, bioengineering bioengineering Application of engineering principles and equipment to biology and medicine. It includes the development and fabrication of life-support systems for underwater and space exploration, devices for medical treatment (see ), marketing and clinical trials management to identify and execute product opportunities for itself and its partners. For more information, visit the Company's website at www.collegiumpharma.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion